Oncimmune Holdings plc (AIM: ONC)
London
· Delayed Price · Currency is GBP · Price in GBX14.48
-0.23 (-1.53%)
Dec 27, 2024, 3:29 PM GMT+1
Oncimmune Holdings Revenue
Oncimmune Holdings had revenue of 1.19M GBP in the half year ending February 29, 2024, a decrease of -17.06%. This brings the company's revenue in the last twelve months to 1.21M, down -62.13% year-over-year. In the fiscal year ending August 31, 2023, Oncimmune Holdings had annual revenue of 1.15M, down -37.82%.
Revenue (ttm)
1.21M
Revenue Growth
-62.13%
P/S Ratio
n/a
Revenue / Employee
31.95K
Employees
38
Market Cap
16.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2023 | 1.15M | -700.80K | -37.82% |
| Aug 31, 2022 | 1.85M | -1.35M | -42.21% |
| May 31, 2022 | 3.21M | -516.00K | -13.86% |
| May 31, 2021 | 3.72M | 3.21M | 631.24% |
| May 31, 2020 | 509.00K | 338.00K | 197.66% |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
| May 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Indivior | 881.89M |
Oncimmune Holdings News
- 4 months ago - Small Cap Stocks: Mercantile Ports, Oncimmune, Ethernity Networks - The Armchair Trader
- 4 months ago - Three Quick Facts: Rightmove, Oncimmune, Vertu Motors - The Armchair Trader
- 5 months ago - Small Cap Stocks: Global Petroleum, Oncimmune - The Armchair Trader